Monitoring requirements Qsymia requires more routine monitoring than GLP-1 medications: Monthly pregnancy tests for women of childbearing age Regular heart rate monitoring Periodic blood work for bicarbonate levels (metabolic acidosis screening) Kidney function tests Mood and cognition assessment GLP-1 medications generally require less intensive monitoring, though periodic blood work to check pancreatic enzymes and kidney function is still recommended
Side effects include, but are not limited to, nausea, diarrhea, vomiting, constipation, abdominal (stomach) pain, headache, fatigue, dyspepsia (indigestion), dizziness, abdominal distension, eructation (belching), hypoglycemia (low blood sugar) in patients with type 2 diabetes, flatulence (gas buildup), gastroenteritis (an intestinal infection) and gastroesophageal reflux disease (a type of digestive disorder)
They depend on a healthy lifestyle
This was maintained until the end of the 12-month follow-up period
What We Cannot Do: We cannot "move" a blood vessel that is physically compressing the nerve (only surgery does that)
Mounjaro contains Tirzepatide, which acts on both GLP-1 and GIP receptors